Morinello E J, Ham A J, Ranasinghe A, Sangaiah R, Swenberg J A
Curriculum in Toxicology and Departments of Pathology, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Chem Res Toxicol. 2001 Mar;14(3):327-34. doi: 10.1021/tx0002076.
We have previously described an immunoaffinity/gas chromatography/electron capture negative chemical ionization high-resolution mass spectrometry (IA/GC/ECNCI-HRMS) assay for quantitation of the promutagenic DNA adduct N(2),3-ethenoguanine (N(2),3-epsilonGua) in vivo. Here we present an expanded assay that allows simultaneous quantitation of its structural isomer, 1,N(2)-ethenoguanine (1,N(2)-epsilonGua), in the same DNA sample. 1,N(2)-epsilonGua and N(2),3-epsilonGua were purified together from hydrolyzed DNA using two immobilized polyclonal antibodies. GC/ECNCI-HRMS was used to quantitate the 3,5-bis(pentafluorobenzyl) (PFB) derivative of each adduct against an isotopically labeled analogue. Selected ion monitoring was used to detect the M - 181 fragments of 3,5-(PFB)(2)-N(2),3-epsilonGua and 3,5-(PFB)(2)-[(13)C(4),(15)N(2)]-N(2),3-epsilonGua and the M - 201 fragments of 3,5-(PFB)(2)-1,N(2)-epsilonGua and 3,5-(PFB)(2)-[(13)C(3)]-1,N(2)-epsilonGua. The demonstrated limits of quantitation in hydrolyzed DNA were 7.6 fmol of N(2),3-epsilonGua and 15 fmol of 1,N(2)-epsilonGua in approximately 250 microg of DNA, which corresponded to 5.0 N(2),3-epsilonGua and 8.7 1,N(2)-epsilonGua adducts/10(8) unmodified Gua bases, respectively. 1,N(2)-epsilonGua was found to be the predominant ethenoguanine adduct formed in reactions of lipid peroxidation products with DNA. The respective ratios of 1,N(2)-epsilonGua to N(2),3-epsilonGua were 5:1 and 38:1 when calf thymus DNA was treated with ethyl linoleate or 4-hydroxynonenal, respectively, under peroxidizing conditions. Only N(2),3-epsilonGua was detected in DNA treated with the vinyl chloride (VC) metabolite 2-chloroethylene oxide and in hepatocyte DNA from rats exposed to 1100 ppm VC for 4 weeks (6 h/day for 5 days/week). These data suggest that 1,N(2)-epsilonGua plays a minor role relative to N(2),3-epsilonGua in VC-induced carcinogenesis, but that 1,N(2)-epsilonGua may be formed to a larger extent from endogenous oxidative processes.
我们之前描述了一种免疫亲和/气相色谱/电子捕获负化学电离高分辨率质谱法(IA/GC/ECNCI-HRMS),用于在体内定量前诱变DNA加合物N(2),3-乙烯基鸟嘌呤(N(2),3-εGua)。在此,我们展示了一种扩展方法,可在同一DNA样品中同时定量其结构异构体1,N(2)-乙烯基鸟嘌呤(1,N(2)-εGua)。使用两种固定化多克隆抗体从水解的DNA中共同纯化1,N(2)-εGua和N(2),3-εGua。GC/ECNCI-HRMS用于针对同位素标记类似物定量每种加合物的3,5-双(五氟苄基)(PFB)衍生物。采用选择离子监测来检测3,5-(PFB)(2)-N(2),3-εGua和3,5-(PFB)(2)-[(13)C(4),(15)N(2)]-N(2),3-εGua的M - 181碎片以及3,5-(PFB)(2)-1,N(2)-εGua和3,5-(PFB)(2)-[(13)C(3)]-1,N(2)-εGua的M - 201碎片。在水解DNA中已证实的定量限为,约250μg DNA中N(2),3-εGua为7.6 fmol,1,N(2)-εGua为15 fmol,分别相当于5.0个N(2),3-εGua和8.7个1,N(2)-εGua加合物/10(8)个未修饰的鸟嘌呤碱基。发现1,N(2)-εGua是脂质过氧化产物与DNA反应中形成的主要乙烯基鸟嘌呤加合物。在过氧化条件下,当小牛胸腺DNA用亚油酸乙酯或4-羟基壬烯醛处理时,1,N(2)-εGua与N(2),3-εGua的各自比例分别为5:1和38:1。在用氯乙烯(VC)代谢物2-氯环氧乙烷处理的DNA以及暴露于1100 ppm VC 4周(每周5天,每天6小时)的大鼠肝细胞DNA中,仅检测到N(2),3-εGua。这些数据表明,在VC诱导的致癌作用中,相对于N(2),3-εGua,1,N(2)-εGua起次要作用,但1,N(2)-εGua可能在更大程度上由内源性氧化过程形成。